Share-based payments (Tables)
|
6 Months Ended |
12 Months Ended |
Jun. 30, 2026 |
Dec. 31, 2025 |
| Notes and other explanatory information [abstract] |
|
|
| Schedule of outstanding options |
Schedule of outstanding options
| | |
For
the six months ended June 30, | |
| | |
2026 | | |
2025 | |
| | |
Number
of options | | |
Weighted
average
exercise
prices | | |
Number
of options | | |
Weighted
average
exercise prices | |
| Outstanding at
beginning of the period | |
| 1,917,529 | | |
| 88.91 | | |
| 1,287,064 | | |
| 115.98 | |
| Granted during the period | |
| - | | |
| - | | |
| - | | |
| - | |
| Exercised during the period | |
| - | | |
| - | | |
| - | | |
| - | |
| Forfeited during the period | |
| (99,142 | ) | |
| 71.73 | | |
| (7,173 | ) | |
| 113.06 | |
| Expired | |
| (22,841 | ) | |
| 77.55 | | |
| (303,236 | ) | |
| 101.31 | |
| Outstanding
at the end of the period | |
| 1,795,546 | | |
| 84.63 | | |
| 976,655 | | |
| 121.01 | |
| Exercisable at the end of
the period | |
| 1,390,379 | | |
| 88.36 | | |
| 903,147 | | |
| 116.80 | |
|
Details
of outstanding options during the year are presented below:
Schedule of outstanding options
| | |
Year ended
December 31,
2025 | | |
Year ended
December 31,
2024 | |
| | |
Number of
options | | |
Weighted average
exercise prices
(SEK) | | |
Number of
options | | |
Weighted average
exercise prices
(SEK) | |
| Outstanding at beginning of the year | |
| 1,287,064 | | |
| 115.98 | | |
| 1,180,392 | | |
| 119.73 | |
| Granted during the year | |
| 1,228,156 | | |
| 71.54 | | |
| 388,420 | | |
| 100.54 | |
| Forfeited during the year | |
| (41,481 | ) | |
| 197.26 | | |
| (96,591 | ) | |
| 111.90 | |
| Exercised during the year | |
| - | | |
| - | | |
| - | | |
| - | |
| Expired during the year | |
| (556,210 | ) | |
| 105.13 | | |
| (185,157 | ) | |
| 109.66 | |
| Outstanding at the end of the year | |
| 1,917,529 | | |
| 88.91 | | |
| 1,287,064 | | |
| 115.98 | |
| Exercisable at the end of the year | |
| 1,419,355 | | |
| 94.36 | | |
| 1,153,020 | | |
| 111.43 | |
|
| Schedule of estimated fair values of options |
|
Schedule
of estimated fair values of options
| | |
31/12/2025 | | |
31/12/2024 | |
| Weighted average share price (SEK) | |
| 62.48 | | |
| 84.71 | |
| Weighted average exercise price (SEK) | |
| 71.54 | | |
| 100.54 | |
| Expected volatility | |
| 35 | % | |
| 35 | % |
| Expected life | |
| 1 | | |
| 4 | |
| Risk-free interest rate | |
| 3.7 | % | |
| 4.4% to 4.7 | % |
| Expected dividend | |
| nil | | |
| nil | |
|
| Schedule of outstanding warrants |
Details
of outstanding warrants during the period are presented below:
Schedule of outstanding warrants
| | |
For
the six months ended June 30, | |
| | |
2026 | | |
2025 | |
| | |
Number
of warrants | | |
Weighted
average
exercise
prices | | |
Number
of warrants | | |
Weighted
average
exercise
prices | |
| Outstanding at
beginning of the period | |
| 1,561,400 | | |
| 72.63 | | |
| - | | |
| - | |
| Granted during the period | |
| - | | |
| - | | |
| - | | |
| - | |
| Exercised during the period | |
| (22,313 | ) | |
| 73.05 | | |
| - | | |
| - | |
| Forfeited during the period | |
| (144,799 | ) | |
| 73.05 | | |
| - | | |
| - | |
| Expired | |
| - | | |
| - | | |
| - | | |
| - | |
| Outstanding
at the end of the period | |
| 1,394,288 | | |
| 72.83 | | |
| - | | |
| - | |
| Exercisable at the end of
the period | |
| 1,098,598 | | |
| 72.85 | | |
| - | | |
| - | |
|
Schedule of outstanding warrants
| | |
Year ended
December 31,
2025 | | |
Year ended
December 31,
2024 | |
| | |
Number of
warrants | | |
Weighted average
exercise prices
(SEK) | | |
Number of
warrants | | |
Weighted average
exercise prices
(SEK) | |
| Outstanding at beginning of the year | |
| - | | |
| - | | |
| - | | |
| - | |
| Granted during the year | |
| 1,561,400 | | |
| 72.63 | | |
| - | | |
| - | |
| Forfeited during the year | |
| - | | |
| - | | |
| - | | |
| - | |
| Exercised during the year | |
| - | | |
| - | | |
| - | | |
| - | |
| Expired during the year | |
| - | | |
| - | | |
| - | | |
| - | |
| Outstanding at the end of the year | |
| 1,561,400 | | |
| 72.63 | | |
| - | | |
| - | |
| Exercisable at the end of the year | |
| 974,199 | | |
| 72.63 | | |
| - | | |
| - | |
|
| Schedule of estimated fair values of warrants |
|
The
weighted average fair value of the warrants granted on those dates is 37.38 while the aggregate of the estimated fair values of the warrants
granted on those dates is SEK 16,719 thousand. The inputs into the Black Scholes model are as follows:
Schedule of estimated fair values of warrants
| | |
31/12/2025 | | |
31/12/2024 | |
| Weighted average share price (SEK) | |
| 37.38 | | |
| - | |
| Weighted average exercise price (SEK) | |
| 72.63 | | |
| - | |
| Expected volatility | |
| 35 | % | |
| - | |
| Expected life | |
| 3 - 5 years | | |
| - | |
| Risk-free interest rate | |
| 3.7% to 4.1 | % | |
| - | |
| Expected dividend | |
| nil | | |
| nil | |
|
| Schedule of fair market value of the warrants |
Details
of outstanding warrants during the six months ended June 30, 2026, and 2025 are presented below:
Schedule of fair market value of the warrants
| | |
2026 | | |
2025 | |
| | |
For
the six months ended June 30, | |
| | |
2026 | | |
2025 | |
| | |
Number
of warrants | | |
Number
of warrants | |
| Outstanding at
beginning of the period | |
| 14,790,565 | | |
| - | |
| Granted during the period | |
| - | | |
| 15,298,552 | |
| Exercised during the period | |
| (12,071,282 | ) | |
| - | |
| Forfeited during the period | |
| (127,351 | ) | |
| - | |
| Expired
during the period | |
| - | | |
| - | |
| Outstanding
at the end of the period | |
| 2,591,932 | | |
| 15,298,552 | |
|
Schedule of fair market value of the warrants
| | |
2025
No. of
warrants | | |
2024
No. of
warrants | |
| Outstanding at the beginning of the year | |
| - | | |
| 8,974,716 | |
| Granted during the year | |
| 14,790,565 | | |
| - | |
| Exercised during the year | |
| - | | |
| (71,100 | ) |
| Forfeited during the year | |
| - | | |
| (581,196 | ) |
| Expired during the year | |
| - | | |
| (8,322,420 | ) |
| Outstanding at the end of the year | |
| 14,790,565 | | |
| - | |
|
| Schedule of consolidated financial statements of loss |
The
shared-based payments are presented in following line items in the interim condensed consolidated financial statements of loss:
Schedule of consolidated financial statements of loss
| (SEK
in thousand) | |
2026 | | |
2025 | |
| | |
For
the six months ended June 30, | |
| (SEK
in thousand) | |
2026 | | |
2025 | |
| Cost of sales | |
| (1,286 | ) | |
| (4 | ) |
| Selling expenses | |
| (2,390 | ) | |
| (9 | ) |
| General and administrative
expenses | |
| (245,348 | ) | |
| (192 | ) |
| Research
and development expenses | |
| (308 | ) | |
| 52 | |
| Total | |
| (249,332 | ) | |
| (152 | ) |
|
|